C. Lau

发表

Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

M. Ladanyi, M. Arcila, C. Lau, 2011, The Journal of molecular diagnostics : JMD.

Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy

Derek Y. Chiang, T. Fennell, K. Cibulskis, 2010, Nature Genetics.

Targeted discovery of novel human exons by comparative genomics.

David Haussler, Mark Diekhans, Phil Green, 2007, Genome research.

Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies

M. Ladanyi, W. Travis, C. Lau, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

Marc Ladanyi, Natasha Rekhtman, B. Reva, 2013, Molecular Cancer Therapeutics.

Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers

N. Girard, M. Ladanyi, C. Begg, 2009, Clinical Cancer Research.

Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas

M. Ladanyi, M. Kris, M. Arcila, 2012, Clinical Cancer Research.

Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling

M. Ladanyi, C. Sima, M. Kris, 2011, Molecular Cancer Therapeutics.

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

Jaime Rodriguez-Canales, James Gao, Sven Bilke, 2014, Nature Genetics.

Mutations of epigenetic regulatory genes are common in thymic carcinomas

P. Meltzer, Yi-Song Wang, G. Giaccone, 2014, Scientific Reports.

Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas

N. Girard, A. Lash, A. Viale, 2009, Clinical Cancer Research.

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans

M. Ladanyi, C. Sima, M. Kris, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ERBB4 mutation analysis: emerging molecular target for melanoma treatment.

C. Lau, Y. Samuels, U. Rudloff, 2014, Methods in molecular biology.

Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases

William Pao, Valerie Rusch, Charuhas Deshpande, 2009, The American journal of surgical pathology.

Absence of common activating mutations of the epidermal growth factor receptor gene in thyroid cancers from American and Japanese patients

M. Ladanyi, C. Lau, J. Ricarte-Filho, 2012, International journal of cancer.

Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma.

A. Lash, M. Ladanyi, M. Kris, 2010 .

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans

M. Ladanyi, C. Sima, M. Kris, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies) trial.

P. Meltzer, Yi-Song Wang, G. Giaccone, 2013 .

Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling

M. Ladanyi, C. Sima, M. Kris, 2011, Molecular Cancer Therapeutics.